Article Versions Notes

Carretero-González A, Lora D, Martín Sobrino I, Sáez Sanz I, Bourlon MT, Anido Herranz U, Martínez Chanzá N, Castellano D, de Velasco G. The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials. Cancers. 2020; 12(7):1945. https://doi.org/10.3390/cancers12071945

Carretero-González, Alberto, David Lora, Isabel Martín Sobrino, Irene Sáez Sanz, María T. Bourlon, Urbano Anido Herranz, Nieves Martínez Chanzá, Daniel Castellano, and Guillermo de Velasco. 2020. "The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials" Cancers 12, no. 7: 1945. https://doi.org/10.3390/cancers12071945

Carretero-González, A., Lora, D., Martín Sobrino, I., Sáez Sanz, I., Bourlon, M. T., Anido Herranz, U., Martínez Chanzá, N., Castellano, D., & de Velasco, G. (2020). The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials. Cancers, 12(7), 1945. https://doi.org/10.3390/cancers12071945